Pharmacology of Antivirals Targeting Metabolism and Immunity

Dear Colleagues,

In this Special Issue, we would like to focus on works related to antiviral agents focusing specifically on immune and metabolic signaling. Drug targets for COVID-19 infection-related pathophysiological mechanisms will be given the utmost importance. Numerous drug targets have been explored for the different viruses and their loads and stages of infection. It is very important to understand in depth the immunological response and metabolic signaling inside the host cells, which could confer protection against viruses and reveal drug targets. Targets ranging from cell surface receptors, membrane components, cytosolic proteins, and even nuclear and mitochondrial proteins are all under study.  We welcome ideas that could lead to the prevention of viral entry or viral multiplication by influencing micro- and macro-environments, altering host cell–virus crosstalks are also of interest. We are interested in antiviral agents derived from naturally occurring compounds, dietary components, metabolic regulators, peptides, novel chemical compounds, biologicals, and RNA-based therapies. For this Special Issue, we will be focusing on the molecular mechanisms of action of these novel agents or perspectives. We welcome articles of all types including original articles, brief reports, viewpoints, mini-reviews, and comprehensive review articles.

Dr. Prasanth Puthanveetil
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.